SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Emisphere
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
272 19 0 EMIS
Emcee:  L. Remmel Type:  Unmoderated
Introduction Market Data Compact
Emisphere (EMIS) has had a significant week, moving from a low of 15 to 20 1/2 on heavy volume; no news has been released. The company developes oral forms of heretofore injected drugs, such as heparin. Does anyone have any reasons for the stock's rise? LR
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
272>>Emisphere Announces License Agreement With Novo Nordisk to Develop Oral tuck-6/23/2008
271Emisphere Announces Executive Management Changes Tuesday January 16, 8:00 am ET kenhott-1/16/2007
270They might have found something in the data pile: Emisphere Technologies, Inc. hmpa-11/3/2006
269The market doesn't like it.technetium-11/2/2006
268As you can see, people do have different feelings about this event. But my opinkenhott-11/1/2006
267<i>All they needed was an efficacious drug</i> Uniformly efficaceoushmpa-10/31/2006
266<i>To get a statistically meaningful reduction in Hba1c levels vs placebo DewDiligence_on_SI-10/31/2006
265To get a statistically meaningful reduction in Hba1c levels vs placebo (metformihmpa-10/31/2006
264investorshub.comDewDiligence_on_SI-10/31/2006
263If you are interested in the company (either way) you'll do yourself a huge hmpa-10/31/2006
262Any comments on the PR?technetium-10/31/2006
261Thanks for the PR. I didn't know (remember) the news was due. Stock was hakenhott-10/30/2006
260Emisphere Technologies Demonstrates Safety and Efficacy of Oral Insulin in Phasescaram(o)uche-10/30/2006
259"As the next week begins 10/30, even if they release the data on Friday 11/technetium-10/28/2006
258<i>Isn’t this long overdue? Treatment ended before labor day.</i> Fohmpa-10/28/2006
257Isn’t this long overdue? Treatment ended before labor day.DewDiligence_on_SI-10/27/2006
256Next week should (or could) see the unblinding of Insulin Phase 2 trial results hmpa-10/27/2006
255Coverage by Andrew Forman from W.R. Hambrecht (Buy, $14 target): wrhambrecht.cohmpa-6/30/2006
254Very happy with the positive performance. And this seems only to be the beginninAlfred W. Post-6/30/2006
253Highly successful SPO today (price up by 17% from the announcement). Hopefully chmpa-5/10/2006
252Information-dense CC today. This company is hard to figure out. investorshub.coDewDiligence_on_SI-5/5/2006
251Emisphere Technologies Announces 2006 First Quarter Preliminary Financial Resulthmpa-5/5/2006
250Emisphere to Receive Milestone Payment for eligen(R) Technology to Be Used in Nehmpa-5/1/2006
249U.S. Federal District Court in Indianapolis Orders Eli Lilly to Assign Intellectnigel bates-4/26/2006
248Emisphere Reports Results of Study Comparing its Oral Heparin Formulation to Tranigel bates-3/31/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News